Ticker Details
Insmed, Inc. Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases.
IPO Date:	June 1, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$23.03B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.50 | 2.84%
Avg Daily Range (30 D):	$3.07 | 2.47%
Avg Daily Range (90 D):	$3.06 | 2.16%

Institutional Daily Volume
Avg Daily Volume:	.87M
Avg Daily Volume (30 D):	2.82M
Avg Daily Volume (90 D):	2.28M

Trade Size
Avg Trade Size (Sh.):	122
Avg Trade Size (Sh.) (30 D):	64
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	10,063
Avg Institutional Trade:	$5.09M
Avg Institutional Trade (30 D):	$7.12M
Avg Institutional Trade (90 D):	$10.38M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$12.24M
Avg Closing Trade (30 D):	$44.06M
Avg Closing Trade (90 D):	$53.78M
Avg Closing Volume:	189.95K

News

May 7, 2026 @ 4:44 PM Nasdaq 100 Climbs Records, Oil Extends Drop As Ira... Source: Piero Cingari

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Mar 21, 2026 @ 11:19 PM This New $193 Million Bet Targets a Biotech With $... Source: Jonathan Ponciano

Jan 6, 2026 @ 10:12 PM Stock Market Today, Jan. 6: Alumis Shares Surge on... Source: Howard Smith

Dec 21, 2025 @ 3:01 PM Nike, Insmed, And Arm Are Among Top 10 Large Cap L... Source: Nabaparna Bhattacharya

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-5.74	$-.76	$-1.53
Diluted EPS	$-5.74	$-.76	$-1.53
Revenue	$819.56M	$305.96M	$263.84M
Gross Profit	$670.48M	$258.54M	$219.62M
Net Income / Loss	$-1183.76M	$-163.56M	$-328.49M
Operating Income / Loss	$-1151.95M	$-153.32M	$-319.75M
Cost of Revenue	$149.08M	$47.42M	$44.22M
Net Cash Flow	$178.94M	$71.74M	$175.68M
PE Ratio

Splits
Mar 03, 2011	1:10
Jul 31, 2000	1:4